公制(单位)
药品
药物发现
计算机科学
计算生物学
药理学
生化工程
化学
风险分析(工程)
医学
生物
工程类
生物化学
运营管理
作者
Rebecca A. Gallego,Martin P. Edwards,T. Patrick Montgomery
标识
DOI:10.1080/17460441.2024.2368744
摘要
INTRODUCTION: Lipophilic efficiency (LipE) and lipophilic metabolic efficiency (LipMetE) are valuable tools that can be utilized as part of a multiparameter optimization process to advance a hit to a clinical quality compound. AREAS COVERED: work and/or to clinical studies. The authors discuss best-practices for using LipE and LipMetE analysis, combined with lipophilicity-focused compound design strategies, to increase the speed and effectiveness of the hit to clinical quality compound optimization process. EXPERT OPINION: It has become well established that increasing LipE and LipMetE within a series of analogs facilitates the improvement of broad selectivity, clearance, solubility, and permeability and, through this optimization, also facilitates the achievement of desired pharmacokinetic properties, efficacy, and tolerability. Within this article, we discuss lipophilic efficiency-focused optimization as a tool to yield high-quality potential clinical candidates. It is suggested that LipE/LipMetE-focused optimization can facilitate and accelerate the drug-discovery process.
科研通智能强力驱动
Strongly Powered by AbleSci AI